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Purpose. The purpose of this review is to provide a summary of laser refractive surgery and corneal inlay approaches to treat
presbyopia in patients after cataract surgery. Summary. The presbyopic population is growing rapidly along with increasing demands
for spectacle independence. This review will focus on the corneal-based surgical options to address presbyopia including various
types of corneal intrastromal inlays and laser ablation techniques to generate either a multifocal cornea (“PresbyLASIK”) or
monovision. The natural history of presbyopia develops prior to cataracts, and these presbyopic surgeries have been largely studied
in phakic patients. Nevertheless, pseudophakic patients may also undergo these presbyopia-compensating procedures for enhanced
quality of life. This review examines the published reports that apply these technologies to patients after cataract surgery and
discusses unique considerations for this population.

1. Introduction
The term “presbyopia” derives from Greek for “old eyes” [1]
and refers to the age-related loss of natural accommodation
and resulting reduction of baseline near vision around the age
of 40 years. As people continue to work and stay active later in
life than ever before, their need for quality vision at both near
and distance vision is also growing. In fact, the presbyopic
population worldwide is predicted to rise to 1.4 billion by
2020 and to 1.8 billion by 2050 [2]. Presbyopia can be compensated by glasses or contact lenses, but there is increasing
interest in surgical options. Since presbyopia is caused by
progressive elasticity changes in the biological crystalline
lens, presbyopic surgeries may either directly replace the
lens through an intraocular approach or modify extraocular
structures such as the cornea or sclera. This review will focus
on corneal-based surgical strategies to treat presbyopia and
in particular how these methods have been or may be used in
pseudophakic patients. To improve uncorrected near vision
in presbyopia, the two major techniques to alter the cornea
generally utilize either an intracorneal inlay device or laser
refractive surgery.

Corneal inlays are devices that are surgically placed
within the corneal stroma of the nondominant eye to change
the optical properties of the cornea. Several different types of
corneal inlays each take a distinct approach to minimizing
presbyopia (Table 1). The best studied inlay to date is the
Kamra inlay by Acufocus, which is an opaque polymer ring
that employs a pinhole concept to expand the depth of focus
[3]. The Raindrop Near Vision Inlay by ReVision Optics is
a clear hydrogel implant that increases the anterior corneal
curvature to add optical power, with a refractive index
approximating that of the cornea [4]. Inlays can also confer
differing amounts of refractive power as in the Flexivue
Microlens implant by Presbia, which creates a multifocal
effect via a central plano zone surrounded by circular rings of
plus power [5]. The Icolens by Neoptics AG is another corneal
inlay with a bifocal design similar in concept to the Flexivue
[6]. Corneal inlays are intended to improve uncorrected near
vision but may come at the cost of lowered distance vision or
increased glare or haloes [7, 8] or rarely infectious keratitis
[9]. However, inlays have been promoted as an additive,
removable technology unlike laser refractive surgery which
ablates corneal tissue [10]; patients usually return to within
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Table 1: Optical principles of corneal inlays.

Optical principle
Small aperture
Corneal reshaping
Refractive optics (multifocality)

Corneal inlay
Kamra
Raindrop Near Vision
Flexivue Microlens, Icolens

+/−1.00 diopter of their preoperative refractive state after
corneal inlay removal [3]. It should be noted that intrastromal
corneal ring segments (ICRS or Intacs) are another type of
corneal implant but are indicated for treatment of keratoconus rather than presbyopia.
Laser refractive surgery on the cornea uses an excimer
laser to remodel the corneal curvature in order to improve
uncorrected vision and reduce dependency on eyeglasses or
contact lenses. One of the most popular techniques, laserassisted in situ keratomileusis (LASIK), removes corneal
stromal tissue under an anterior flap. LASIK can produce
either monovision or multifocality, the latter of which has
been nicknamed “PresbyLASIK” when it is used to treat
presbyopia. Conventional monovision LASIK corrects the
dominant eye for distance vision and the nondominant eye
for near vision [15]. PresbyLASIK usually follows one of three
different approaches to multifocal corneal ablation [16]. In
central PresbyLASIK, the central area is shaped hyperpositively for near vision, whereas the midperipheral cornea is
adjusted for far vision. In peripheral PresbyLASIK, the central
area is shaped for far vision and the midperipheral corneal
area for near vision. In the third approach, laser blended
vision creates a combination of micromonovision and depth
of field increase by inducing spherical aberration. There
are concerns for the decreased contrast sensitivity, visual
quality, and irreversibility of these laser ablation procedures.
Laser blended vision treatment seems to provide the best
compromise in terms of safety and quality of vision [16].

2. Corneal Inlays for Presbyopia
In contrast to the literature on corneal inlays in phakic
patients, there are only a handful of published reports
in pseudophakic individuals (Table 2). These include only
case reports and retrospective case series. The largest study
of pseudophakic patients undergoing inlay implantation
included 13 patients with monofocal intraocular lenses (IOLs)
[12]. Four of these patients also underwent simultaneous
LASIK to optimize their underlying refractive error prior to
insertion of a Kamra pinhole inlay. The mean uncorrected
near visual acuity (UNVA) improved 5 lines from J10 to
J4 at 3 months postoperatively, without significant change
in mean uncorrected or corrected distance visual acuity
(UDVA, CDVA) or corrected near visual acuity (CNVA). On
a postoperative survey, 77% of the patients said they would
opt to have the surgery again. In an earlier report by the same
group, Kamra inlays were inserted in the nondominant eye
of 3 patients with phakic IOL implants [11]. These patients
saw 2–5 lines of improvement in UNVA without change in
UDVA at 3 months postoperatively. Both of these studies had
a short follow-up period of 3 months, at which point the

authors assert that operative results would have stabilized.
Nonetheless, longer studies are definitely needed as the mean
age of these patients was around 55 years and so the patients
would be expected to live with the inlays for several decades.
Two case reports with slightly longer follow-up each
described a pseudophakic patient who retained improvement
of uncorrected near vision at 6–24 months after a corneal
inlay procedure. One young patient at 32 years of age had
received a monofocal IOL on account of a traumatic cataract
in the right eye, and a year later he developed headaches
and asthenopia while reading with his right eye [14]. Given
his requirement of a +3.00 reading add in the right eye,
he could not tolerate glasses due to anisometropia. After
Kamra inlay implantation, he reported improved symptoms
but also slightly worse reading in dim light compared to
bright light conditions. His UNVA improved from J17 to
J3 in the operated eye at the 6-month follow-up. Another
pseudophakic patient with a monofocal IOL saw a J3 to
J1 improvement in UNVA after implantation of a Flexivue
Microlens inlay 6 months after the cataract extraction [13].
This recovery of uncorrected near vision continued to be
maintained at a 2-year follow-up after inlay implantation.
Interestingly, this patient developed a symptomatic posterior
capsule opacification in the operated eye at 2 years after
the cataract surgery, underwent standard neodymium:YAG
(Nd:YAG) capsulotomy, and was reported to still be satisfied
and spectacle free with UNVA of J1 6 months later. The
authors asserted that the transparent design of this particular
inlay enabled visualization for the Nd:YAG capsulotomy and
also fundoscopy.
The aforementioned studies demonstrate the efficacy
of corneal inlays in presbyopes with a history of prior
intraocular and/or refractive surgery. Such a history is an
exclusion factor for many other studies on inlays. Similar
studies done in phakic patients suggest that the improved
uncorrected near vision is achieved for at least 1 to 5 years after
corneal inlay implantation. A Mexican prospective study of
30 phakic patients undergoing inlay implantation (Raindrop
Near Vision Inlay) and LASIK demonstrated improvement
of mean UNVA by 3 lines at one year [4], suggesting that
the improved UNVA could also be stable at one year in
pseudophakes. A larger retrospective study of 277 eyes in
Japan showed similar results at one year after simultaneous
Kamra inlay implantation and LASIK, with mean UNVA
improving from J8–J10 to J2-J3 depending on patient age
[17]. The longest published follow-up of inlays involved
an Austrian prospective cohort of 32 emmetropic phakic
patients who retained improved uncorrected near vision at
5 years after Kamra inlay implantation [18]. Of note, the
mean UNVA enhancement declined somewhat from J1 to
J3 between the 3- and 5-year time points; however, CDVA
did not change. It is worth mentioning that, by the 5-year
follow-up, there were still no biocompatibility concerns and
84% of the patients said they would opt for the surgery again.
Several complications occurred, including 2 inlays needed to
be recentered, 1 eye that required debridement for epithelial
ingrowth, 18 eyes that developed iron deposits by year 3, and 1
inlay that was removed at year 3 due to patient dissatisfaction.

6 months

2 years

3 months

3 months

Length of
follow-up

J17 to J3

6/10 to 6/5

Change in monocular (and binocular) visual
acuities for uncorrected distance and near vision
Change in UNVA
Change in UDVA (tested at 20
(tested at 30 cm)
feet unless otherwise indicated)
2–5 lines (J4 to J2, J6
No change in mean
to J4, and J10 to J5)
5 lines mean
improvement (J10 to
No change in mean
J4)
J3 to J1 (binocular J3
20/25 to 20/32 (binocular 20/20,
to J1)
no change)

N.B. Intermediate visual acuity was not reported in any of these studies. Except where indicated, binocular visual acuities were not reported in these studies.

Kamra (simultaneous LASIK)

1, monofocal IOL

Huseynova et
al., 2014 [12]

Kamra
(2 patients had prior LASIK)
Kamra
(4 patients underwent
simultaneous or prior LASIK)
Presbia Microlens

13, monofocal IOLs

Huseynova et
al., 2013 [11]

Technique

1, monofocal IOL

3, phakic IOLs

Publication

Stojanovic et al.,
2014 [13]
Ziaei and
Mearza, 2013
[14]

Number of
patients, IOL type

Table 2: Published studies of corneal inlays in pseudophakic patients.

Not mentioned

Not mentioned

“Standard bright
light conditions”

Not mentioned

Illumination
conditions
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There are several case reports describing the opposite
sequence of events, where patients with prior corneal inlay
implantation subsequently undergo cataract extraction with
intraocular lens placement, either with or without initially
removing the inlay. These patients had previously received
any one of the three major corneal inlay types, including
the Kamra inlay [19], Presbia Microlens inlay [20], and the
Raindrop Near Vision Inlay [21]. These anecdotes suggest
that cataract surgery can still be successfully performed after
inlay implantation, which will be important for those young
presbyopes opting for surgical treatment of their presbyopia.

3. Laser Refractive Surgery for Presbyopia
An extensive review of the literature on laser refractive
surgery for presbyopia revealed very few studies done in
pseudophakic patients, although there are numerous published accounts in phakic patients. Similar to the body of literature on corneal inlays, a history of prior intraocular surgery
such as cataract extraction typically excluded such patients
from studies on laser refractive surgery for presbyopia.
Nonetheless, laser refractive surgery has been performed successfully on pseudophakes to correct for ametropias [22–25],
suggesting that laser refractive surgery to address presbyopia
is likely to be equally successful in pseudophakic patients
who have monofocal IOLs. Clearly, the application of laser
refractive surgery to presbyopia in pseudophakia merits more
research.
Various studies examine the efficacy of laser refractive
surgery on treating presbyopia in phakic patients. A prospective trial of central multifocal PresbyLASIK on 50 hyperopicpresbyopic eyes resulted in spectacle independence at all distances for 72% of the patients after 6 months, although nearly
a third lost 1-2 lines of CDVA [26]. This and similar studies
have suggested that multifocal laser approaches to improving
uncorrected near vision in presbyopia may compromise distance vision to some degree [27–29]. Another study utilizing
peripheral PresbyLASIK improved mean binocular UDVA
and UNVA with high reported patient satisfaction rates but
decreased contrast sensitivity [30]. PresbyLASIK treatment
for presbyopia may be further modified in pseudophakic
patients who are not satisfied with the outcome, as described
in a recent case report using a wavefront-guided aspheric
treatment to reverse the presbyopic treatment and eliminate
dysphotopsia up to 6 months later [29].
LASIK and photorefractive keratectomy (PRK) are
known to be effective for fine-tuning residual ametropias
after presbyopia-compensating IOL implantation [31], which
suggests that laser refractive surgery could similarly address
presbyopia after IOL implantation. Sixty-four pseudophakic
eyes maintained improved vision at 4 years after LASIK
[32]. Two subsequent studies showed efficacy of LASIK at
up to 6 months in treating pseudophakic ametropia after
multifocal IOL implantation in 53 eyes [33] and 85 eyes with
mixed ametropias [23]. PRK has also been used to treat
pseudophakic ametropia after multifocal IOL implantation
[34]. These and other similar studies suggest that laser
refractive surgery could also be used in pseudophakes to treat
presbyopia. A general consensus is that LASIK should be
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performed at least 6–12 weeks after intraocular surgery to
reduce possible complications related to cataract incisions,
postoperative corneal edema, and refractive and IOL stability
[31]. While PRK and LASIK have both been performed
safely in pseudophakic patients, it has been postulated that
neither are as effective as primary refractive surgery [25].
Conductive keratoplasty (CK), a corneal refractive surgical
technique that uses radiofrequency energy to reshape the
central cornea by shrinking peripheral collagen, has also been
used to treat presbyopia. While again the majority of studies
only include phakic patients, one Chinese study reported
that CK improved UNVA up to one year later in presbyopic
pseudophakic patients with monofocal IOLs [35].
Studies have noted that myopes and hyperopes may
express different levels of satisfaction with PresbyLASIK as
well as with other presbyopic treatments. Although near
acuity results tend to be better in myopes, the majority of
hyperopes are satisfied whereas the majority of myopes are
not [16]. The decreasing visual quality after PresbyLASIK in
myopes who have experienced excellent uncorrected near
visual acuity preoperatively can lead to dissatisfaction over
unmet expectations.

4. Patient Factors and Expectations:
Special Considerations for Pseudophakia
Pseudophakic patients present a unique set of challenges and
advantages for presbyopic surgeries as compared to the phakic population. Some of the challenges stem from the prior
intraocular surgery itself, such as navigating corneal scars and
residual corneal irregularities from prior incisions. Additionally, IOL aberrations may alter laser refractive measurements
and calculations normally used on phakic eyes [31]. In general, the age difference of approximately two decades between
pseudophakic patients and typical refractive patients also
renders keratorefractive treatments less predictable and less
effective [25]. The older age of most pseudophakic patients
correlates with increased prevalence of dry eye symptoms
and slower healing rates. Studies have suggested that the final
uncorrected visual acuity after excimer laser or corneal inlay
surgery is lower in pseudophakic patients than in typical
refractive patients [36].
On the other hand, older patients have reported similar
or higher levels of satisfaction after presbyopic surgeries as
compared with younger patients who may have had higher
postoperative acuity expectations [17, 36]. Presbyopia may
continue to progress for phakic individuals who undergo
refractive or inlay procedures at a younger age, whereas this
is not an issue for patients who have had cataract surgery. At
the same time, the lack of residual natural accommodative
power in pseudophakic patients gives little room for error in
presbyopic surgeries. It is worth noting, however, that because
the IOL treats most of the spherical error in pseudophakic
patients, there would be less keratorefractive-induced effect
on the corneal prolate asphericity and quality of vision than
in nonametropic phakic patients [25].
In all patients, regardless of phakic status, there are
certain considerations to optimize a satisfactory outcome

Journal of Ophthalmology
from corneal-based presbyopic surgeries. The importance of a
thorough preoperative evaluation cannot be understated, and
trial frames or contact lenses should be used in various lighting conditions to help develop realistic patient expectations.
Patients should be selected appropriately from baseline characteristics including tear film adequacy, normal corneal shape
and thickness, and reasonable expectations. There need to be
more studies and counseling of patients on possible negative
outcomes of presbyopic surgeries, ranging from increased dry
eye or glare symptoms to decreased distance and/or night
vision and subsequent safety concerns. Presbyopic surgery
may not completely eliminate the need for reading glasses.
Given the necessity of fundus viewing for diagnosis and treatment of diseases such as age-related macular degeneration,
diabetic retinopathy, or retinal detachments, it should be considered that corneal inlays may obstruct the view or hinder
treatment unless they are first removed. Although corneal
inlays are promoted as removable, long-term follow-up on
removed inlays is not available and PresbyLASIK procedures
are in general not reversible with the commonly available
technology at present. As the first wave of refractive patients
begins to require cataract surgery, we may be required to
change not only the assessment and technique of cataract
surgery for these patients, but also how we counsel these
patients who have high expectations for visual acuity and
spectacle independence.

5. Conclusions
For patients suffering from presbyopia, there are now exciting
surgical alternatives to glasses and contact lenses. Pseudophakic patients who still desire better uncorrected near vision
may choose corneal-based surgical therapies, such as corneal
inlays or laser refractive surgery. Nevertheless, presbyopic
surgeries will not be ideal for all patients, and appropriately
screening patients and managing patient expectations are
both key to maximizing satisfactory outcomes. Many studies
on presbyopic surgeries excluded patients with prior ocular
surgery, and the few published studies on pseudophakic
patients are limited by short-term follow-up, small numbers,
and limited lighting conditions. Undoubtedly, there is a
pressing need for more research on presbyopic surgeries in
the pseudophakic population.
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[25] C. S. Sáles and E. E. Manche, “Managing residual refractive error
after cataract surgery,” Journal of Cataract & Refractive Surgery,
vol. 41, no. 6, pp. 1289–1299, 2015.
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